Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
07/11/1991 | WO1990009449A3 Candida tropicalis transformation system |
07/11/1991 | DE4000247A1 Additives for increasing activity of enzymes acting on nucleic acids - comprising milk or its components or prods. |
07/11/1991 | CA2072563A1 Method of separating haemopoietic progenitor cells |
07/11/1991 | CA2072356A1 Diagnosis and treatment of diseases |
07/10/1991 | EP0436508A2 Mutant microorganisms useful for cleavage of organic C-S bonds |
07/10/1991 | EP0436502A2 Novel glucose isomerases with an altered pH optimum |
07/10/1991 | EP0436467A2 Expression of S-locus specific glycoprotein gene in transgenic plants |
07/10/1991 | EP0436400A1 Intracelluar antigen found in subpopulation of CD8+T lymphocytes and monoclonal antibody reactive with same |
07/10/1991 | EP0436355A2 Process for producing 7-aminocephem compound or salts thereof |
07/10/1991 | EP0436003A1 Production of heterologous proteins in plants and plant cells |
07/10/1991 | EP0435957A1 Dna damage-binding factor and uses therefor |
07/10/1991 | EP0435911A1 Cell culture medium for enhanced cell growth, culture longevity and product expression. |
07/10/1991 | EP0435877A1 Polynucleotides that encode the human proteoglycan peptide core of the effector cells of the immune response |
07/10/1991 | CN1052897A Subtilisin mutants |
07/10/1991 | CN1052896A Recombinant herpesvirus of turkeys and live vector vaccines derived thereof |
07/09/1991 | WO1991010684A1 Oxidized variants of gm-csf |
07/09/1991 | US5030722 Odorant-binding protein from rat |
07/09/1991 | US5030717 Antibodies which catalyze hydrolysis of ester bonds |
07/09/1991 | US5030576 For screening drugs, immunoassays |
07/09/1991 | US5030574 Plasmidless Lac strain of bacilus megaterium QM B1551 |
07/09/1991 | US5030570 Genetic engineering |
07/09/1991 | US5030567 Method for production of L-phenylalanine by recombinant E. coli ATCC 67460 |
07/09/1991 | US5030566 Concatemeric DNA length standards |
07/09/1991 | US5030564 Monoclonal antibody specific to the lymphokine LK 2 and its method of production |
07/09/1991 | US5030563 Bacterial hypersecretion using mutant repressor sequence |
07/09/1991 | US5030559 Methods and compositions for the identification of metastatic human tumors |
07/09/1991 | US5030557 Helper oligonucleotides binding to target nucleic acid to effect a different secondary and tertiary structure to facilit ate binding of the probe |
07/09/1991 | US5030556 Species-specific DNNA probe for the detection of Branhamella catarrhalis |
07/09/1991 | US5030426 Biomining of gallium and germanium containing ores |
07/09/1991 | US5030425 Biodegradation and recovery of gallium and other metals from integrated circuits |
07/09/1991 | US5030240 Perhydrolysis; cleaning compounds |
07/09/1991 | CA2072587A1 Oxidized variants of gm-csf |
07/09/1991 | CA1285895C Yeast production of hepatitis b surface antigen |
07/09/1991 | CA1285869C Assay method and diagnostic system for a marker of abnormal lipid metabolism |
07/06/1991 | WO1991009874A1 Novel fibronectin receptor |
07/06/1991 | CA2072013A1 Fibronectin receptor |
07/06/1991 | CA2033644A1 Intracellular antigen found in subpopulation of cd8+t lymphocytes and monoclonal antibody reactive with same |
07/06/1991 | CA2032937A1 Mutant microorganisms useful for cleavage of organic c-s bonds |
07/05/1991 | WO1991009614A1 GPIbα FRAGMENTS AND RECOMBINANT DNA EXPRESSION VECTORS |
07/05/1991 | CA2072753A1 Gpi.beta.o fragments and recombinant dna expression vectors |
07/04/1991 | DE4042160A1 New gene for Flavobacterium N-acetyl:mannosamine dehydrogenase - expressed efficiently in E. coli, useful as reagent for diagnostic assay of sialic acid |
07/03/1991 | WO1991009949A1 Target-specific, cytotoxic, recombinant pseudomonas exotoxin |
07/03/1991 | EP0435776A1 Artificial promoter for protein expression in yeast |
07/03/1991 | EP0435725A1 DNA having the genetic information of phospholipase D and its use |
07/03/1991 | EP0435617A1 Bovine myogenic factor gene |
07/03/1991 | EP0435229A1 DNA of non-A, non-B hepatitis virus gene, its clone and use thereof |
07/03/1991 | EP0435185A1 Anti-human myocardial C protein monoclonal antibody and hybridoma producing the antibody |
07/03/1991 | EP0435150A2 Amplification capture assay |
07/03/1991 | EP0435028A2 Procedure for releasing poly-3-hydroxycarboxylic acids |
07/03/1991 | EP0434992A1 Enteroviral polypeptide and group-specific detection of enterovirus infection |
07/03/1991 | EP0434909A2 Anticoagulant and antihelminthic proteins and methods for the production and use of same |
07/03/1991 | EP0434751A1 A malaria antigen |
07/03/1991 | EP0434747A1 Viral vaccines |
07/03/1991 | EP0434721A1 Viral nucleotide sequences |
07/03/1991 | EP0151128B1 Monoclonal antibodies reactive with endotoxin core |
07/03/1991 | CN1052695A Transfer genes method and particle gun |
07/03/1991 | CN1052608A Bcrfl proteins as inhibitors of interferon-gamma |
07/02/1991 | US5028694 Antigenic proteins and vaccines containing them for prevention of coccidiosis caused by eimeria Eimeria necatrix and Eimeria tenella |
07/02/1991 | US5028588 Blood substitutes |
07/02/1991 | US5028586 Eliminating some or all of the acid containing side chains by esterification or replacement of glutamic acid residues with glutamine, prolonged action |
07/02/1991 | US5028539 Ethanol production using engineered mutant E. coli |
07/02/1991 | US5028534 DNA clones of human placental plasminogen activator inhibitor |
07/02/1991 | US5028533 Precursor polypeptide, DNA sequence coding therefor, vectors host organisms, and processes involving same |
07/02/1991 | US5028530 AraB promoters and method of producing polypeptides, including cecropins, by microbiological techniques |
07/02/1991 | US5028527 Diagnosis of leukemia, reaction with oncogenic proteins |
07/02/1991 | US5028426 Deletion mutant of pseudorabies virus and vaccine containing said virus |
07/02/1991 | US5028424 Antibodies to receptor and antigen for natural killer and non-specific cytotoxic cells |
07/02/1991 | US5028420 Muteins of tumor necrosis factor |
07/02/1991 | CA1285699C Process for solubilization, purification and characterization ofprotein from insoluble protein aggregates or complexes and compositions of matter therefrom |
07/02/1991 | CA1285507C Hybrid interferons |
07/02/1991 | CA1285506C Shuttle vectors from rhodococcus equi |
07/02/1991 | CA1285505C Stable dna constructs containing as selectable markers, genes whose products are essential for normal cell growth on complex media |
06/30/1991 | WO1991009973A2 C. difficile specific oligonucleotides |
06/30/1991 | WO1991009960A1 Hybrid protein c |
06/30/1991 | WO1991009956A1 Artificial promoter for expressing proteins in yeast |
06/30/1991 | CA2066027A1 C. difficile specific oligonucleotides |
06/30/1991 | CA2033247A1 Expression of s-locus specific glycorpotein gene in transgenic plants |
06/29/1991 | WO1991009875A1 Monoclonal antibody, hybridomas, their production and use |
06/29/1991 | CA2069872A1 Monoclonal antibody, hybridomas, their production and use |
06/28/1991 | WO1991010139A1 Method for detecting malignant diseases |
06/28/1991 | WO1991009974A1 Diagnostic probe for detecting human stomach cancer |
06/28/1991 | CA2070995A1 Diagnostic probe for detecting human stomach cancer |
06/28/1991 | CA2046888A1 Method for the detection of malignant diseases |
06/28/1991 | CA2033116A1 System for isolating and producing new genes, gene products and dna sequences |
06/27/1991 | WO1991009310A1 Free fatty acid determination |
06/27/1991 | WO1991009140A1 Probe for detection of the fragile x syndrome |
06/27/1991 | WO1991009137A1 Recombinant thyrotropin receptor |
06/27/1991 | WO1991009131A1 Cloning vector for use in lactic acid bacteria |
06/27/1991 | WO1991009130A1 Fermentation process for the production of pyrimidine deoxyribonucleosides |
06/27/1991 | WO1991009128A1 Dna, constructs, cells and plants derived therefrom |
06/27/1991 | WO1991009124A1 Variants of pai-2 |
06/27/1991 | WO1991009123A1 Soluble cd4 having a decreased affinity for mhc class ii antigens |
06/27/1991 | WO1991009122A1 A recombinant human factor viii derivative |
06/27/1991 | WO1991009121A2 Polypeptides having thyrotropin-receptor activity, nucleic acid sequences coding for such receptors and polypeptides, and applications of these polypeptides |
06/27/1991 | WO1991009116A1 Genetic protection of animals against infection by the bovine leukemia virus, and provirus and recombinant virus derived from this virus |
06/27/1991 | WO1991009060A1 Proteinase inhibitory agents and methods for their use |
06/27/1991 | WO1991009059A1 Antibody antagonists of human interleukin-4 |
06/27/1991 | WO1991009058A1 Therapeutic uses of the hypervariable region of monoclonal antibody m195 and constructs thereof |
06/27/1991 | WO1991009057A1 Novel proteins with oncostatin m activity and process for their preparation |
06/27/1991 | WO1991009050A1 Novel organ-specific plant promoter sequences |